FDA Inspection 1323272 - Dr. Amira Al-Uzri, M.D. - June 18, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dr. Amira Al-Uzri, M.D.

Record Details

This FDA Inspection record concerns Dr. Amira Al-Uzri, M.D., with an inspection on June 18, 2026, issued by the Seattle District Office, covering human drugs.

Company: Dr. Amira Al-Uzri, M.D.
Inspection Date: June 18, 2026
Product Type: Human Drugs
Office: Seattle District Office

Open in Dashboard

ID · 7ee07ab5-b309-47aa-a8df-6907645c1ad3

Violation Codes3

21 CFR 312.62(b)21 CFR 312.62(c)21 CFR 50.55(e)(2)

Full citation text and observation details available on the Dashboard.